Discover
NVCT
Nuvectis Pharma, Inc.
21.12
2 x 14.79
1 x 20.93
bid
ask
+
0.99
4.92%
2 @ 04:00 PM
21.12 +0.00 (0.00%)
| Ytd | 179.74% | |
| 1y | 251.41% |
19.88
day range
21.26
5.55
52 week range
29.27
| Open | 20.11 | Prev Close | 20.13 | Low | 19.88 | High | 21.26 | Mkt Cap | 689.44M |
| Vol | 152.96K | Avg Vol | 214.31K | EPS | -1.31 | P/E | N/A | Forward P/E | -4.77 |
| Beta | -0.24 | Short Ratio | 5.30 | Inst. Own | 6.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 21.77 | 200-d Avg | 13.79 | 1yr Est | 22.00 |
NVCT News
globenewswire.com
Nuvectis Pharma to Participate in the Maxim Growth Summit 2026
Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutic
benzinga.com
HC Wainwright & Co. Reiterates Buy on Nuvectis Pharma, Maintains $39 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Nuvectis Pharma (NASDAQ:NVCT) with a
benzinga.com
Nuvectis Pharma's NXP200 BRAF Inhibitor Receives China's Breakthrough Therapy Designation
Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage